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a  b  s  t  r  a  c  t
Pluronic  block  copolymers  L61  and  L121 were  reacted  with  succinic  anhydride  to  produce,  respec-
tively,  their  mono-  and  bisderivatives  with  succinic  acid.  The  critical  micelle  concentration  of  Pluronics
decreased  after  modiﬁcation.  The  modiﬁcation  of  Pluronic  L61  promoted  its association  with  the plasma
membrane  of human  cells  and  increased  membrane  damage,  while  the  membranotropic  activity  of
modiﬁed  Pluronic  L121  reduced  compared  to the  initial  copolymer.  Modiﬁed  Pluronics  interfered  with
the  viability,  apoptosis  induction  and metabolism  of  A549  cells  and  skin  ﬁbroblasts  to  a much  lesser
extent  presumably  due  to the  introduction  of succinic  acid residue  inhibited  intracellular  penetration
of  copolymers.  Modiﬁed  Pluronic  L121  promoted  the  cellular  uptake  of doxorubicin  and  rhodamine  123
in A549  cells  attributed  to the  inhibition  of  membrane  P-glycoprotein.  Our study  provides  an  approach
to  assessing  the  mechanism  of interaction  of  amphiphilic  polymers  with  living  cells  and  demonstrates
that  Pluronic–succinic  acid conjugates  can be used  as  safe  and efﬁcient  modulators  of intracellular  drug
delivery.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
To date, biomedical science has generated a vast number of
active substances in the treatment of a variety of human dis-
eases. In clinical trials the biological safety, and/or efﬁciency of the
substances developed was often not proven [1]. One of the main
reasons is that exogenous substances naturally possess a limited
ability to pass through the body’s barriers, resulting in their insufﬁ-
cient therapeutic concentration at organ-tissue/cellular levels. The
use of adjuvant compounds to improve pharmacokinetics and facil-
itate intracellular delivery of existing therapeutics is becoming a
topical approach in drug development [2,3].
Both natural and synthetic polymers provide an efﬁcient
tool in promoting the delivery of drugs to their cellular tar-
gets. Such polymers are generally designed as inert carriers
that allow: increasing circulation time, a stability of adminis-
tered drugs and the improvement of their biodistribution [3,4].
In particular, covalent conjugates of cytostatic agents with N-(2-
hydroxypropyl) methacrylamide and polyglutamic acid have been
introduced to suppress tumor growth [5]. Modiﬁcation of peptide
and oligonucleotide-based therapeutics with polyethylene glycol
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(PEG) has become a common route to improving their biological
properties [6,7].
Another concept is that some synthetic polymers can be
used as efﬁcient modulators of biological response at cellular
and molecular level rather than as inert drug carriers [8,9].
A promising class of such biologically active polymers is non-
ionogenic amphiphilic polyethers, speciﬁcally tri-block copolymers
of ethylene oxide (EO) and propylene oxide (PO) with the gen-
eral formula (EO)x–(PO)y–(EO)x (PluronicsTM). Depending on the
hydrophilic–lipophilic balance (HLB) and molecular weight (MW),
these polyethers exhibit different biological effects. Pluronics of
low and medium HLB, e.g. Pluronics L61 and P85, were shown to
substantially facilitate the accumulation of ﬂuorophores and small
drug molecules in human cells that overproduce membrane efﬂux
transporters, e.g. multidrug resistance protein 1 (P-glycoprotein)
[8–10]. High expression of P-glycoprotein in multidrug-resistant
(MDR) cancer cells and brain capillary endothelial cells leads to
the rapid exclusion of many xenobiotics including cytotoxic drugs
taken into the cell [8,11].
Possible ways of Pluronic-medicated intracellular drug delivery
include: facilitating the passive diffusion of a substance across the
cell plasma membrane, the promotion of lysosomal release, and the
inhibition of P-glycoprotein ATPase activity by altering the mem-
brane ﬂuidity and/or the suppression of adenosine-5′-triphosphate
(ATP) production in mitochondria [8,9]. The inhibition of the
efﬂux transporter, such as P-glycoprotein is believed to especially
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